Evidence map›Paper›PMID 41562946›Full record

ArticleJournal of eye movement research2025

The Impact of Ophthalmic Lens Power and Treatments on Eye Tracking Performance.

Marta Lacort-Beltrán, Adrián Alejandre, Sara Guillén, Marina Vilella, Xian Pan, Victoria Pueyo, Marta Ortin, Eduardo Esteban-Ibañez

Abstract read
In one paragraph

Article in Journal of eye movement research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta Lacort-BeltránDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0009-0001-7757-2627
Adrián AlejandreDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0000-0002-8140-1396
Sara GuillénDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0009-0004-0524-3527
Marina VilellaDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0000-0002-5592-8442
Xian PanDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0000-0001-8492-2050
Victoria PueyoAragón Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.ORCID 0000-0002-1777-0349
Marta OrtinDIVE Medical S.L., 50009 Zaragoza, Spain.
Eduardo Esteban-IbañezDIVE Medical S.L., 50009 Zaragoza, Spain.ORCID 0000-0003-1788-9128

Funding

MICIU/AEI/10.13039/501100011033 DIN2021-012296Vicerrectorado de Transferencia e Innovación Tecnológica from Universidad de Zaragoza DI 7/2020
6 · The paper itself

Abstract

Eye tracking (ET) technology is increasingly used in both research and clinical practice, but its accuracy may be compromised by the presence of ophthalmic lenses. This study systematically evaluated the influence of different optical prescriptions and lens treatments on ET performance using DIVE (Device for an Integral Visual Examination). Fourteen healthy participants underwent oculomotor control tests under thirteen optical conditions: six with varying dioptric powers and six with optical filters, compared against a no-lens control. Key parameters analysed included angle error, fixation stability (bivariate contour ellipse area, BCEA), saccadic accuracy, number of data gaps, and proportion of valid frames. High-powered spherical lenses (+6.00 D and -6.00 D) significantly increased gaze angle error, and the negative lens also increased data gaps, while cylindrical lenses had a moderate effect. Among filters, the Natural IR coating caused the greatest deterioration in ET performance, reducing valid samples and increasing the number of gaps with data loss, likely due to interference with the infrared-based detection system. The lens with basic anti-reflective treatment (SV Org 1.5 AR) also showed some deterioration in interaction with the ET. Other filters showed minimal or no significant impact. These findings demonstrate that both high-powered prescriptions and certain lens treatments can compromise ET data quality, highlighting the importance of accounting for optical conditions in experimental design and clinical applications.

Indexed as

eye trackinginfrared filtersoculomotor controlophthalmic lensesperformance

Identifiers

PMID41562946
PMCPMC12821570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.